These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4798816)

  • 21. The clinical relevance of platelet function tests.
    McBride JA; Wallett LH
    Br J Haematol; 1972 Sep; 23():Suppl:201-8. PubMed ID: 4567192
    [No Abstract]   [Full Text] [Related]  

  • 22. Congenital platelet disorders and understanding of platelet function.
    Nurden AT; Nurden P
    Br J Haematol; 2014 Apr; 165(2):165-78. PubMed ID: 24286193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet factor 4 in platelet disorders--storage location and the requirement of endogenous ADP for its release.
    Weiss HJ; Rogers J
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):30-5. PubMed ID: 4683252
    [No Abstract]   [Full Text] [Related]  

  • 24. Possible thrombosthenin defect in Glanzmann's thrombasthenia.
    Booyse F; Kisieleski D; Seeler R; Rafelson M
    Blood; 1972 Mar; 39(3):377-81. PubMed ID: 4110434
    [No Abstract]   [Full Text] [Related]  

  • 25. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease.
    Weiss HJ; Tschopp TB; Baumgartner HR
    N Engl J Med; 1975 Sep; 293(13):619-23. PubMed ID: 1080251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of aspirin and indomethacin on the platelet contractile wave.
    Gerrard JM; White JG
    Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet dysfunction in myeloproliferative syndromes.
    Phadke K; Dean S; Pitney WR
    Am J Hematol; 1981; 10(1):57-64. PubMed ID: 7258182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin D2 inhibits the aggregation of human platelets.
    Smith JB; Silver MJ; Ingerman CM; Kocsis JJ
    Thromb Res; 1974 Sep; 5(3):291-9. PubMed ID: 4439372
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet dysfunction in essential thrombocythaemia.
    Stathakis NE; Papayannis AG; Arapakis G; Gardikas C
    Ann Clin Res; 1974 Aug; 6(4):198-202. PubMed ID: 4473953
    [No Abstract]   [Full Text] [Related]  

  • 30. Thromboxane synthesis and the platelet release reaction in Bernard-Soulier syndrome, thrombasthenia Glanzmann and Hermansky-Pudlak syndrome.
    Malmsten C; Kindahl H; Samuelsson B; Levy-Toledano S; Tobelem G; Caen JP
    Br J Haematol; 1977 Apr; 35(4):511-520. PubMed ID: 559512
    [No Abstract]   [Full Text] [Related]  

  • 31. Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction.
    Smith JB; Ingerman C; Kocsis JJ; Silver MJ
    J Clin Invest; 1974 May; 53(5):1468-72. PubMed ID: 4825236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aspirin-like defect - a hereditary thrombocytopathy due to impaired release of platelet adenosine diphosphate].
    Elezović I; Mijović A; Rolović Z
    Bilt Hematol Transfuz; 1979; 7(2-3):165-74. PubMed ID: 263623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet disorders. Advances in understanding and management.
    Aster RH
    Postgrad Med; 1974 May; 55(5):50-5. PubMed ID: 4856841
    [No Abstract]   [Full Text] [Related]  

  • 35. Release reaction in washed platelet suspensions induced by kaolin and other particles.
    Cronberg S; Caen JP
    Scand J Haematol; 1971; 8(2):151-60. PubMed ID: 4999379
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects on platelet aggregation of oral prostaglandin E2 used for the induction of labour.
    Myatt L; Elder MG
    Br J Obstet Gynaecol; 1975 Jun; 82(6):449-52. PubMed ID: 1138835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins.
    Phillips DR; Agin PP
    J Clin Invest; 1977 Sep; 60(3):535-45. PubMed ID: 70433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some effects of a microcrystalline collagen preparation on blood.
    Mason RG; Read MS
    Haemostasis; 1974; 3(1):31-45. PubMed ID: 4215704
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion.
    Weiss HJ; Willis AL; Kuhn D; Brand H
    Br J Haematol; 1976 Feb; 32(2):257-72. PubMed ID: 1247498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenylbutazone inhibition of equine platelet function.
    Meyers KM; Lindner C; Katz J; Grant B
    Am J Vet Res; 1979 Feb; 40(2):265-70. PubMed ID: 464364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.